Global Cancer Diagnostic Devices Market - New Research by Technavio

Technavio has published a new market research report on the global cancer diagnostic devices market from 2018-2022. (Graphic: Business Wire)

LONDON--()--Market research firm Technavio has announced the release of their latest report on the global cancer diagnostic devices market. This new report will provide expert market insights for the forecast period 2018-2022.

The report will follow up on Technavio’s previous cancer diagnostic devices research, offering an up-to-date analysis of the market concerning the current market scenario, latest trends and drivers, and the overall global environment. The report also provides new predictions for the forecast period based on an in-depth analysis of the market.

The upgraded research report on the cancer diagnostic devices market is an integral part of Technavio’s in-vitro diagnostics portfolio. Technavio covers an extensive range of market research reports on the in-vitro diagnostics market, covering different regions and top industry segments. Some of the topics include clinical reference laboratory services, infectious disease diagnostic testing, bloodstream infection testing, liquid biopsy, tissue diagnostics, and autoimmune disease diagnostics.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Opportunities for growth in the cancer diagnostic devices market

Technavio’s previous report on the global cancer diagnostic devices market projected that the Americas showed the highest potential in 2015 with a market share of nearly 53% when compared to APAC and EMEA. The Americas comprise of many well-known medical facilities, which focus on targeted therapeutic methods to treat different types of cancers. The availability of a large number of medical facilities in the Americas led to the strong growth of this market.

In the previous report, a senior research analyst at Technavio stated, “The need for cost-cutting by pharma companies is a key market driver powering the growth of the cancer diagnostic devices market. From drug development, the pharmaceutical companies are shifting their focus to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a crucial role in helping pharmaceutical companies develop specific drugs to treat cancer. Increase in investments in diagnostic device development will enhance market growth.”

Technavio’s new on the report on the global cancer diagnostic devices market will evaluate the key geographical regions and their behavior over the past four years, introducing new data and observations and providing new predictions.

Looking for the latest information on the global cancer diagnostic devices market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Detailed analysis at your fingertips

Some of the topics that will be revisited in the new report include:

  • Market size and growth rate through 2022
  • Top factors driving the market growth
  • Emerging trends in the market
  • Market opportunities and factors impeding growth

The report on the global cancer diagnostic devices market for the period 2018-2022 is available to order now and will be delivered within one week of purchase.


Save big with Technavio this May!

Find out what companies are venturing in to beat the heat this summer! Technavio indulges you with a massive 20% OFF on all

non-alcoholic beverages reports for the entire month.


Technavio honors the achievements and efforts of Motherhood this Mother's Day by offering a whopping 30% OFF on all cosmetics and toiletry reports. Offer valid from 7th May for a limited period.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

Market research firm Technavio has announced the release of their latest report on the global cancer diagnostic devices market for 2018-2022.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200